about
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewThe cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytesThe G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells.Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia.Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia.Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR TechniquesA molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia.Janus kinase 2 inhibitors in myeloproliferative disorders.Epigenetic regulation in myelodysplastic syndromes: implications for therapy.Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium.Emerging biological insights and novel treatment strategies in multiple myeloma.Perspectives in the treatment of multiple myeloma.An old drug with a new future: bendamustine in multiple myeloma.Promising therapies for the treatment of chronic lymphocytic leukemia.Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.Bendamustine in multiple myeloma.Ixazomib for the treatment of multiple myeloma.The role of tandem stem cell transplantation for multiple myeloma patients.Sorafenib for the treatment of multiple myeloma.lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcomePanobinostat for the treatment of acute myelogenous leukemia.Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes.A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells.Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells.Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.Rituximab for the treatment of patients with chronic lymphocytic leukemiaMobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study.The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat.
P50
Q26770716-10AC1663-4C46-4505-9E25-CF138D362F97Q33815579-E280D169-3738-48E5-A1C2-B12949E28B69Q34314290-0989C918-D03F-47FC-9657-EBCCDFD0A99CQ34458590-A13D1FE1-50E3-4385-B8DC-220B0A407D9FQ34978154-ABB81067-4F09-4439-BFF5-4815FD242415Q35140580-16E84477-F4AB-4087-B0B5-B498FDD00AF1Q35192691-ADBFF03F-9700-446A-B7BC-4CE7A02C4F6EQ35674595-19E88A08-8F9D-4D42-B511-3599F8E2F809Q36425924-52117DD0-9F43-4091-BFE1-CFF35BAD646BQ37179155-7E4AF7F6-B8E0-43BA-8856-6F17F0EB1491Q37815509-3DFF1D33-2FBF-4AAD-B964-DE05093953E5Q37850456-6394DDE8-F6EA-4D9D-8AF3-C1B466BC32B8Q37996560-56AE3E1F-86C0-43B9-B246-07B0AC756E91Q38016513-34E3FF8C-68F2-45DB-B80B-F5EC9E5A76C8Q38037600-B5E3ECD7-E566-4977-BB21-C6E4A0DF6D88Q38108391-AB2A49B3-E5DB-4369-B00C-D19E85D67235Q38139989-766CB610-64EC-4402-8899-A87FBFD8CECDQ38366441-8B72F816-0812-447E-B5D2-0F01AC3D8F1DQ38410532-455C1F90-C067-47F4-8685-806718623BB7Q38530583-54EE4189-09D5-4F39-8EAF-E764E139C9E5Q38542172-B2379B5D-E45B-43E2-AF83-9A1828A14C6BQ38677358-58EE6835-C932-4F03-8CBA-820C32291F61Q38783055-5E28E049-AB8D-4772-A038-76A2D6EF2DEAQ38822886-BB71E752-18BC-48FE-94A8-8E73C980A979Q38835113-C1F65966-20BC-4616-B872-394CF9DD75ACQ39039713-C3B194C7-F957-4941-BD6A-EC9A3F0F96D1Q39901137-F572E22B-5867-4375-B4DB-1EE1B3E767EAQ39952025-83DC3D09-BEE5-4C74-8871-143BD0BBC38EQ40363380-356E54F7-7D15-4845-96B2-1C1E21F5B0E6Q40550442-E0105BFA-802D-4DBC-9DCF-96DCEABDEE78Q40593846-BFC0DDED-3FB7-40BA-9F04-275EF5E86769Q40601612-C2AD4C77-F2E9-4000-99B9-3CE1EEA977AEQ41092333-5A448AFE-83E0-4B5B-8ED0-D6686CA57B74Q41241909-EDE5F5E6-135F-41A2-A1AA-4DCA4F2A32E5Q41505002-68125353-DD58-4659-8F40-2EF1861858B5Q42336286-D60C0169-434E-43F8-BD2A-EFF5A3110E57Q42507670-070DCF26-29BD-44B6-BBF9-B6C65AF32BA8Q42711562-58B375B8-E9B2-4BEC-AE54-86C9B928C990Q43037951-B115651B-96C5-4DF1-9842-046565E93DA5Q43197276-E7FF6F78-ABD4-452D-9DE8-43E2F2E67A48
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Grazia Recchia
@ast
Anna Grazia Recchia
@en
Anna Grazia Recchia
@es
Anna Grazia Recchia
@nl
Anna Grazia Recchia
@sl
type
label
Anna Grazia Recchia
@ast
Anna Grazia Recchia
@en
Anna Grazia Recchia
@es
Anna Grazia Recchia
@nl
Anna Grazia Recchia
@sl
prefLabel
Anna Grazia Recchia
@ast
Anna Grazia Recchia
@en
Anna Grazia Recchia
@es
Anna Grazia Recchia
@nl
Anna Grazia Recchia
@sl
P106
P1153
6701342554
P21
P31
P3835
anna-grazia-recchia2
P496
0000-0001-5748-2002